SAB BIO Stock Explodes 54% on Game-Changing $175 Million Private Placement Deal
The biotech sector just got a massive jolt of excitement, and SAB Biotherapeutics (NASDAQ: SABS) is leading the charge! As of this writing, SAB BIO shares are absolutely rocketing in pre-market trading, surging over 54% after the company announced an oversubscribed $175 million private placement that has Wall Street talking. When you see a stock … Read more